Log in
OTCMKTS:CDEV

Centennial Resource Development Stock Forecast, Price & News

$1.21
+0.10 (+9.01 %)
(As of 12/2/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.04
Now: $1.21
$1.26
50-Day Range
$0.55
MA: $0.80
$1.27
52-Week Range
$0.24
Now: $1.21
$5.35
Volume9.07 million shs
Average Volume11.42 million shs
Market Capitalization$336.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Centennial Resource Development, Inc., an independent oil and natural gas company, focuses on the development of unconventional oil and associated liquids-rich natural gas reserves in the United States. The company's assets primarily focus on the Delaware Basin, a sub-basin of the Permian Basin. Its properties consist of acreage blocks primarily in Reeves County in West Texas and Lea County in New Mexico. As of December 31, 2019, it leased or acquired approximately 78,195 net acres; and owned 1,569 net mineral acres in the Delaware Basin. The company was formerly known as Silver Run Acquisition Corporation and changed its name to Centennial Resource Development, Inc. in October 2016. Centennial Resource Development, Inc. was incorporated in 2015 and is headquartered in Denver, Colorado.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Oil & Gas E&P
Sub-IndustryN/A
SectorEnergy
Current SymbolOTCMKTS:CDEV
CUSIPN/A
CIKN/A
Phone720-499-1400
Employees195

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$336.79 million
Next Earnings DateN/A
OptionableOptionable
$1.21
+0.10 (+9.01 %)
(As of 12/2/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CDEV News and Ratings via Email

Sign-up to receive the latest news and ratings for CDEV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Centennial Resource Development (OTCMKTS:CDEV) Frequently Asked Questions

How has Centennial Resource Development's stock price been impacted by COVID-19 (Coronavirus)?

Centennial Resource Development's stock was trading at $0.4920 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CDEV shares have increased by 145.9% and is now trading at $1.21.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Centennial Resource Development?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centennial Resource Development in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Centennial Resource Development
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Centennial Resource Development?

Wall Street analysts have given Centennial Resource Development a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Centennial Resource Development wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Centennial Resource Development's earnings last quarter?

Centennial Resource Development, Inc. (OTCMKTS:CDEV) posted its quarterly earnings data on Monday, November, 2nd. The company reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.03. The firm earned $149.10 million during the quarter, compared to analyst estimates of $115.94 million.
View Centennial Resource Development's earnings history
.

Who are some of Centennial Resource Development's key competitors?

What other stocks do shareholders of Centennial Resource Development own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Centennial Resource Development investors own include BioCryst Pharmaceuticals (BCRX), Fluidigm (FLDM), OPKO Health (OPK), Aimmune Therapeutics (AIMT), Blue Apron (APRN), Alteryx (AYX), Bloom Energy (BE), Continental Resources (CLR), Co-Diagnostics (CODX) and Cronos Group (CRON).

Who are Centennial Resource Development's key executives?

Centennial Resource Development's management team includes the following people:
  • Mr. Sean R. Smith, CEO & Director (Age 47, Pay $1.12M)
  • Mr. George S. Glyphis, CFO, VP & Assistant Sec. (Age 50, Pay $1.01M)
  • Mr. Brent P. Jensen, Chief Accounting Officer & VP (Age 50, Pay $671.96k)
  • Mr. Davis O. O'Connor, VP & Gen. Counsel (Age 65, Pay $840.06k)
  • Mr. Matt R. Garrison, VP & COO
  • Mr. Hays Mabry, Director of Investor Relations
  • Ms. Kathleen M. Phillips, VP of HR
  • Mr. Stephen S. Coats, Sec. (Age 49)
  • Mr. William A. Weidig, VP of Fin. & Treasurer
  • Ms. Jamie L. Wheat, VP of Accounting (Age 50)

What is Centennial Resource Development's stock symbol?

Centennial Resource Development trades on the OTCMKTS under the ticker symbol "CDEV."

How do I buy shares of Centennial Resource Development?

Shares of CDEV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Centennial Resource Development's stock price today?

One share of CDEV stock can currently be purchased for approximately $1.21.

How big of a company is Centennial Resource Development?

Centennial Resource Development has a market capitalization of $336.79 million. Centennial Resource Development employs 195 workers across the globe.

What is Centennial Resource Development's official website?

The official website for Centennial Resource Development is www.cdevinc.com.

How can I contact Centennial Resource Development?

The company can be reached via phone at 720-499-1400.

This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.